Form 4: Immunome Director Jean Jacques Bienaime Acquires 7,800 Shares

Director Jean Jacques Bienaime purchased 7,800 shares of Immunome Inc. (IMNM) at an average price of $7.78 on March 25, 2025.

Summary

• On March 25, 2025, Jean Jacques Bienaime, a director of Immunome Inc. (IMNM), acquired 7,800 shares of common stock.
• The purchase was made at a weighted average price of $7.78 per share, with prices ranging from $7.37 to $8.51.
• Following the transaction, Bienaime directly owns 31,415 shares of Immunome Inc.
• The transaction was reported on a Form 4 filed with the SEC on March 26, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's valuation and future performance. It is a common practice and is regulated by the SEC to prevent insider trading.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Immunome, IMNM, Jean Jacques Bienaime, Director, Stock Purchase, Form 4, SEC Filing, Beneficial Ownership